198 related articles for article (PubMed ID: 18813831)
1. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells.
Shennan DB; Thomson J
Oncol Rep; 2008 Oct; 20(4):885-9. PubMed ID: 18813831
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
3. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
[TBL] [Abstract][Full Text] [Related]
4. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
Yamauchi K; Sakurai H; Kimura T; Wiriyasermkul P; Nagamori S; Kanai Y; Kohno N
Cancer Lett; 2009 Apr; 276(1):95-101. PubMed ID: 19058911
[TBL] [Abstract][Full Text] [Related]
5. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK
Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
[TBL] [Abstract][Full Text] [Related]
6. L-leucine transport in human breast cancer cells (MCF-7 and MDA-MB-231): kinetics, regulation by estrogen and molecular identity of the transporter.
Shennan DB; Thomson J; Gow IF; Travers MT; Barber MC
Biochim Biophys Acta; 2004 Aug; 1664(2):206-16. PubMed ID: 15328053
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK
Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654
[TBL] [Abstract][Full Text] [Related]
8. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T
Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327
[TBL] [Abstract][Full Text] [Related]
9. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
[TBL] [Abstract][Full Text] [Related]
10. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T
Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
Takabe W; Kanai Y; Chairoungdua A; Shibata N; Toi S; Kobayashi M; Kodama T; Noguchi N
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1640-5. PubMed ID: 15178563
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
13. L-type amino acid transporter 1 inhibitors inhibit tumor cell growth.
Oda K; Hosoda N; Endo H; Saito K; Tsujihara K; Yamamura M; Sakata T; Anzai N; Wempe MF; Kanai Y; Endou H
Cancer Sci; 2010 Jan; 101(1):173-9. PubMed ID: 19900191
[TBL] [Abstract][Full Text] [Related]
14. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.
Atluri H; Talluri RS; Mitra AK
Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592
[TBL] [Abstract][Full Text] [Related]
15. Functional and molecular characteristics of system L in human breast cancer cells.
Shennan DB; Thomson J; Barber MC; Travers MT
Biochim Biophys Acta; 2003 Apr; 1611(1-2):81-90. PubMed ID: 12659948
[TBL] [Abstract][Full Text] [Related]
16. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
[TBL] [Abstract][Full Text] [Related]
17. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
19. Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells.
Yoon JH; Kim IJ; Kim H; Kim HJ; Jeong MJ; Ahn SG; Kim SA; Lee CH; Choi BK; Kim JK; Jung KY; Lee S; Kanai Y; Endou H; Kim DK
Cancer Lett; 2005 May; 222(2):237-45. PubMed ID: 15863273
[TBL] [Abstract][Full Text] [Related]
20. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
